SLC5A2 and Hepatic steatosis: A recent meta-analysis by Mantovani et al. also confirmed the significant effect on hepatic steatosis, though up to now, no results on the histological response of SGLT-2 inhibitors are available, at least not from randomized placebo-controlled trials (223, 224).